Species-specific and inhibitor-dependent conformations of LpxC: implications for antibiotic design.

LpxC is an essential enzyme in the lipid A biosynthetic pathway in gram-negative bacteria. Several promising antimicrobial lead compounds targeting LpxC have been reported, though they typically display a large variation in potency against different gram-negative pathogens. We report that inhibitors with a diacetylene scaffold effectively overcome the resistance caused by sequence variation in the LpxC substrate-binding passage. Compound binding is captured in complex with representative LpxC orthologs, and structural analysis reveals large conformational differences that mostly reflect inherent molecular features of distinct LpxC orthologs, whereas ligand-induced structural adaptations occur at a smaller scale. These observations highlight the need for a molecular understanding of inherent structural features and conformational plasticity of LpxC enzymes for optimizing LpxC inhibitors as broad-spectrum antibiotics against gram-negative infections.

[1]  I. Mochalkin,et al.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB‐78485 inhibitor , 2008, Protein science : a publication of the Protein Society.

[2]  W. Hunter,et al.  The nucleotide-binding site of Aquifex aeolicus LpxC , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

[3]  Pei Zhou,et al.  Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis. , 2008, Current pharmaceutical biotechnology.

[4]  D. Whittington,et al.  Amphipathic benzoic acid derivatives: synthesis and binding in the hydrophobic tunnel of the zinc deacetylase LpxC. , 2007, Bioorganic & medicinal chemistry.

[5]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[6]  N. Andersen,et al.  Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC. , 2002, Journal of medicinal chemistry.

[7]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[8]  C. Fierke,et al.  Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Randy J Read,et al.  Automated structure solution with the PHENIX suite. , 2008, Methods in molecular biology.

[10]  Robert A. Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery , 2013 .

[11]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[12]  D. Christianson,et al.  Binding of uridine 5'-diphosphate in the "basic patch" of the zinc deacetylase LpxC and implications for substrate binding. , 2006, Biochemistry.

[13]  M. Pirrung,et al.  High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties. , 2003, Journal of the American Chemical Society.

[14]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[15]  C. Fierke,et al.  Site-directed mutagenesis of the bacterial metalloamidase UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC). Identification of the zinc binding site. , 2001, Biochemistry.

[16]  D. S. Riggs,et al.  A COMPARISON OF ESTIMATES OF MICHAELIS-MENTEN KINETIC CONSTANTS FROM VARIOUS LINEAR TRANSFORMATIONS. , 1965, The Journal of biological chemistry.

[17]  Lori I Robins,et al.  Structural basis for the sugar nucleotide and acyl-chain selectivity of Leptospira interrogans LpxA. , 2009, Biochemistry.

[18]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[19]  M. Pirrung,et al.  Antibacterial Agents That Target Lipid A Biosynthesis in Gram-negative Bacteria , 2000, The Journal of Biological Chemistry.

[20]  Brian E. Coggins,et al.  Structure of the LpxC deacetylase with a bound substrate-analog inhibitor , 2003, Nature Structural Biology.

[21]  C. Fierke,et al.  UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine Deacetylase Functions through a General Acid-Base Catalyst Pair Mechanism* , 2005, Journal of Biological Chemistry.

[22]  K. Nicolaou,et al.  The endiandric acid cascade. Electrocyclizations in organic synthesis. 3. "Biomimetic" approach to endiandric acids A-G. Synthesis of precursors , 1982 .

[23]  Raetz Cr.  Enzymes of lipid A biosynthesis: targets for the design of new antibiotics. , 1998 .

[24]  J. Rudolph,et al.  A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin. , 2005, Biochemistry.

[25]  A. Williams,et al.  Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase , 2007, Proceedings of the National Academy of Sciences.

[26]  Pei Zhou,et al.  Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding , 2007, Proceedings of the National Academy of Sciences.

[27]  C. Raetz,et al.  Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.

[28]  C. Raetz.  Enzymes of lipid A biosynthesis: targets for the design of new antibiotics. , 1998, Progress in clinical and biological research.

[29]  C. Fierke,et al.  Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase. , 2006, Biochemistry.

[30]  R. Lattimer,et al.  Synthesis, characterization, and crystal structures of two strained cyclic diacetylenes and their precursors , 1998 .

[31]  Pei Zhou,et al.  Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli. , 2007, Biochemistry.

[32]  Clinical,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .

[33]  J. Rudolph,et al.  Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design. , 2005, Biochemistry.